SGSeda Gozel

Seda Gozel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seda Gozel has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An 11-Year Comprehensive Retrospective Study on the Prevalence and Genotype Distribution of Human Papillomavirus (HPV) in Women and Men in Türkiye and Northern Cyprus

    by Tutku Taskinoglu, Zafer Yazici, Seda Gozel, Adem Keskin, Melek Bilgin, Tugce Cuneydioglu, Mehmet Hakan Taskin

    Background/Objectives: Human papillomavirus (HPV) is one of the most widespread sexually transmitted infections (STIs) worldwide. The aim of the present study was to evaluate the prevalence and genotype distribution of HPV in Türkiye and Northern Cyprus. Methods: In the present study, we analysed HPV results recruited from 37 health centres in Türkiye and Northern Cyprus between 2015 and 2025. Briefly, the presence and genotypes of HPV were detected with two different diagnostic kits. Results: A total of 37,458 molecular test results were evaluated in this study. Overall, 9732 (25.98%) individuals who underwent at least one HPV test were positive. The mean age of HPV-positive individuals was 34.87 ± 9.62 years. HPV positivity was higher in women than in men. The highest HPV positivity rate (41.13%) was observed among individuals younger than 25 years. High-risk (HR) HPV accounted for 42.27% of the 9732 HPV-positive individuals identified in this study. The most common HPV genotypes were 16, 18, and 6, respectively. HPV genotypes 42 and 35 were observed more frequently in women than in men, whereas genotypes 39, 59, and 68 were more prevalent in men. HPV 6 and 11 were most observed in individuals younger than 25 years. Multiple-type infections were most frequently observed in individuals younger than 25 years. Single-type HPV infections were commonly detected in those aged 50–59 years and in individuals over 60 years. Conclusions: These findings contribute to our understanding of epidemiological data on HPV genotype distribution in Türkiye and provide meaningful comparisons across age groups. This study may increase public awareness of HPV infection and help public health authorities develop effective prevention strategies.

  • Open Access

    A Retrospective Assessment of HIV Prevalence in the Central Black Sea Region of Türkiye

    by Mehmet Hakan Taskin, Sule Ozturk, Esra Tas, Reyhan Caliskan, Ergin Kariptas, Ecem Dilara Aygun, Seda Gozel, Zafer Yazici, Ahmed Eisa Elhag

    Background: HIV has been a major global health issue since the 1980s. The proportions of diagnosed and undiagnosed infections are important indicators of HIV control. This study investigated the prevalence and characteristics of HIV based on blood samples from patients presenting for diagnosis and treatment at a tertiary healthcare hospital in the Central Black Sea Region over a four-year retrospective period. Methods: We retrospectively evaluated 271,367 samples submitted for anti-HIV serology testing for pre-operative screening or clinical suspicion between 2020 and 2023. HIV-1/2 antibodies and p24 antigen were screened using chemiluminescence microparticle immunoassay (CMIA), and reactive samples were confirmed by real-time RT-PCR. HIV RNA results and immunological parameters were also analyzed. Results: Among 271,367 samples, 694 were HIV-positive, yielding a prevalence of 0.25%. Of 2207 individuals tested for HIV RNA, 699 (31.7%) were positive. HIV RNA positivity was higher in men than women (35.5% vs. 18.6%). Absolute CD4+ T-cell counts were similar between genders, while the CD4/CD8 ratio was significantly higher in women. Both CD4+ T-cell counts and CD4/CD8 ratios increased significantly after three months of treatment. Conclusions: This study demonstrates a low but increasing HIV seroprevalence in the region, with a clear predominance among males and young adults. The findings also reflect effective viral suppression among treated patients and significant immunological recovery after therapy, providing important regional data to guide HIV monitoring and public health interventions.